Assessment and Treatment Decisions in HIV/HCV Co-Infection
PROGRAM DESCRIPTION People with HIV infection are disproportionately affected by viral hepatitis. The CDC reports that in the United States, 25% of people living with HIV are co-infected with hepatitis ...
PROGRAM DESCRIPTION
People with HIV infection are disproportionately affected by viral hepatitis. The CDC reports that in the United States, 25% of people living with HIV are co-infected with hepatitis C virus (HCV), and about 10% are co-infected with hepatitis B virus (HBV). HCV co-infection is responsible for a five-fold increase in hospitalizations and has become a leading cause of complications and morality among people with HIV.To better manage the risk of viral hepatitis in this population, people with HIV should be screened for HCV infection annually and before starting antiretroviral therapy (ART).1,2HIV/HCV co-infections can be effectively managed in many people, but treatment is complex.In this activity, you will learn how to how effectively identify at-risk patients and screen for HCV co-infection, select appropriate treatment plans, and gain a better understanding of the recommended guidelines for treating and managing HIV/HCV co-infection.Module 5 of HealthHIV’s HIV Primary Care Training and Certificate Program is designed to build upon previous modules deepening primary care providers’ understanding of HIV epidemiology, diagnosis, and management by familiarizing them with recommended guidelines for treating and managing HIV/HCV co-infection.
EDUCATIONAL OBJECTIVES
After completing this activity, the participant will demonstrate the ability to:Identify indications for the treatment of chronic HCV infection and reasons to consider delaying HCV treatment in patients with HIV/HCV co-infectionExplain the reported safety and efficacy of currently available treatments for HCV in patients co-infected with HIVList HCV/HIV drug combinations to avoid based on potential for drug-drug interactionsSelect guidelines-recommended monitoring for patients being treated for HCV/HIV co-infection
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags